Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sulpiride 70mg/5ml oral liquid
0402010U0AAAWAW
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpitil 200mg tablets
0402010U0BCAAAH
|
Sulpitil | Sulpiride | Central Nervous System | No data available |
|
Sulpor 200mg/5ml oral solution
0402010U0BFAAAE
|
Sulpor | Sulpiride | Central Nervous System | No data available |
|
Sultiame 100mg tablets
0408010Y0AAADAD
|
Sultiame | Sultiame | Central Nervous System | No data available |
|
Sultiame 20mg/ml oral suspension
0408010Y0AAAEAE
|
Sultiame | Sultiame | Central Nervous System | No data available |
|
Sultrin Triple Sulfa cream with applicator
0702020W0BBAAAA
|
Sultrin | Preparations for other vaginal infections | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Sumar Lite dressing 10cm x 10cm
20030200150
|
Sumar Lite dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumar Lite dressing 10cm x 15cm
20030200151
|
Sumar Lite dressing 10cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumar Lite dressing 5cm x 5cm
20030200152
|
Sumar Lite dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumar Max dressing 10cm x 10cm
20030200155
|
Sumar Max dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumar Max dressing 10cm x 15cm
20030200156
|
Sumar Max dressing 10cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumar Max dressing 5cm x 5cm
20030200157
|
Sumar Max dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumar Spiral dressing 0.5cm x 40cm
20030200159
|
Sumar Spiral dressing 0.5cm x 40cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sumatriptan 85mg / Naproxen 457mg tablets
0407041AEAAAAAA
|
Sumatriptan succinate/Naproxen sodium | Sumatriptan succinate/Naproxen sodium | Central Nervous System | No data available |
|
Sunitinib 12.5mg capsules
0801050AMAAAAAA
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 25mg capsules
0801050AMAAABAB
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 37.5mg capsules
0801050AMAAADAD
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 50mg capsules
0801050AMAAACAC
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunnyvale organic rye bread with sunflower seeds sliced
0904010U0BKACAA
|
Sunnyvale (Gluten free wheat free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Sunsense anti-ageing face matte lotion SPF 50+
130801000BBPDA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Sunsense sport gel SPF 30
130801000BBLSA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
SunVit-D3 10,000units/ml oral drops
0906040G0BWBMDN
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | No data available |
|
SunVit-D3 2,400units/ml oral drops
0906040G0BWBKDQ
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | No data available |
|
SunVit-D3 2,740units/ml oral drops
0906040G0BWBGDT
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | No data available |
|
SunVit-D3 25,000units/2.5ml oral solution
0906040G0BWBLDP
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.